COST

924.4

+0.57%↑

PG

147.99

-0.05%↓

KO

70.94

-0.76%↓

PM

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

PG

147.99

-0.05%↓

KO

70.94

-0.76%↓

PM

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

PG

147.99

-0.05%↓

KO

70.94

-0.76%↓

PM

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

PG

147.99

-0.05%↓

KO

70.94

-0.76%↓

PM

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

PG

147.99

-0.05%↓

KO

70.94

-0.76%↓

PM

154.04

-0.76%↓

PEP

145.37

-0.38%↓

Search

Lifecore Biomedical Inc

Aperta

SettoreConsumatore difensivo

7.87 -1.01

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

7.48

Massimo

7.98

Metriche Chiave

By Trading Economics

Entrata

13M

-2M

Vendite

1.3M

36M

EPS

-0.253

Margine di Profitto

-5.617

Dipendenti

406

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

15M

241M

Apertura precedente

8.88

Chiusura precedente

7.87

Notizie sul Sentiment di mercato

By Acuity

50%

50%

67 / 148 Classifica in Consumer defensive

Lifecore Biomedical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 nov 2025, 21:34 UTC

Utili

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13 nov 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13 nov 2025, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13 nov 2025, 23:41 UTC

Discorsi di Mercato

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13 nov 2025, 23:24 UTC

Utili

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13 nov 2025, 23:24 UTC

Utili

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13 nov 2025, 23:23 UTC

Utili

JBS NV 3Q EPS 52c >JBS

13 nov 2025, 23:23 UTC

Utili

JBS NV 3Q Sales $22.6B >JBS

13 nov 2025, 23:04 UTC

Discorsi di Mercato

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13 nov 2025, 22:02 UTC

Utili

Nu Holdings 3Q Net $783M >NU

13 nov 2025, 22:01 UTC

Utili

Nu Holdings 3Q Rev $4.2B >NU

13 nov 2025, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13 nov 2025, 21:50 UTC

Utili

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13 nov 2025, 21:45 UTC

Acquisizioni, Fusioni, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13 nov 2025, 21:41 UTC

Acquisizioni, Fusioni, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13 nov 2025, 21:36 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13 nov 2025, 21:36 UTC

Acquisizioni, Fusioni, Takeovers

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13 nov 2025, 21:36 UTC

Acquisizioni, Fusioni, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13 nov 2025, 21:36 UTC

Acquisizioni, Fusioni, Takeovers

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13 nov 2025, 21:36 UTC

Acquisizioni, Fusioni, Takeovers

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13 nov 2025, 21:33 UTC

Discorsi di Mercato

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13 nov 2025, 21:33 UTC

Utili

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13 nov 2025, 21:31 UTC

Utili

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13 nov 2025, 21:25 UTC

Utili

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13 nov 2025, 21:25 UTC

Utili

Figure Tech Solutions 3Q EPS 34c >FIGR

13 nov 2025, 21:23 UTC

Utili

Intchains Group 3Q Rev $1.3M >ICG

13 nov 2025, 21:03 UTC

Utili

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13 nov 2025, 21:02 UTC

Utili

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13 nov 2025, 21:01 UTC

Utili

Applied Materials 4Q Rev $6.8B >AMAT

13 nov 2025, 21:01 UTC

Utili

Applied Materials 4Q Gross Margin 48.0% >AMAT

Confronto tra pari

Modifica del prezzo

Lifecore Biomedical Inc Previsione

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

2

Acquista

2

Mantieni

0

Vendi

Sentiment

By Acuity

67 / 148 Classifica in Consumatore difensivo

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
help-icon Live chat